Evaluating patient-reported fatigue and serum biomarkers in axial spondyloarthritis

Rheumatology (Oxford). 2020 Oct 1;59(10):3111-3113. doi: 10.1093/rheumatology/keaa115.

Authors

Elizabeth Reilly^{1

2}, Anita McGrogan², Raj Sengupta¹

Affiliations

¹ Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Royal United Hospital NHS Trust.
² Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.

PMID: 32259246
DOI: 10.1093/rheumatology/keaa115

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adaptor Proteins, Signal Transducing / blood*
Adult
Biomarkers / blood
Cross-Sectional Studies
Databases, Factual
Fatigue / blood*
Fatigue / etiology
Female
HLA-B27 Antigen / blood*
Humans
Male
Middle Aged
Patient Reported Outcome Measures
Spondylarthritis / blood*
Spondylarthritis / complications
Spondylarthritis / drug therapy
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Vascular Endothelial Growth Factor A / blood*

Substances

Adaptor Proteins, Signal Transducing
Biomarkers
HLA-B27 Antigen
MAPKAP1 protein, human
Tumor Necrosis Factor-alpha
VEGFA protein, human
Vascular Endothelial Growth Factor A